Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–405.

Article  CAS  PubMed  Google Scholar 

Swerdlow SH, World Health O, International Agency for Research on C. WHO classification of tumours of haematopoietic and lymphoid tissues. Rev. 4th ed. Lyon: International Agency for Research on Cancer; 2017. 585 pages: illustrations p.

Makishima H, Saiki R, Nannya Y, Korotev S, Gurnari C, Takeda J, et al. Germ line DDX41 mutations define a unique subtype of myeloid neoplasms. Blood. 2023;141(5):534–49.

Article  CAS  PubMed  Google Scholar 

Feurstein S, Trottier AM, Estrada-Merly N, Pozsgai M, McNeely K, Drazer MW, et al. Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages. Blood. 2022;140(24):2533–48.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Molteni E, Bono E, Galli A, Elena C, Ferrari J, Fiorelli N, et al. Prevalence and clinical expression of germ line predisposition to myeloid neoplasms in adults with marrow hypocellularity. Blood. 2023;142(7):643–57.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Godley LA, Shimamura A. Genetic predisposition to hematologic malignancies: management and surveillance. Blood. 2017;130(4):424–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tsai FD, Lindsley RC. Clonal hematopoiesis in the inherited bone marrow failure syndromes. Blood. 2020;136(14):1615–22.

PubMed  PubMed Central  Google Scholar 

Schratz KE. Clonal evolution in inherited marrow failure syndromes predicts disease progression. Hematol Am Soc Hematol Educ Program. 2023;2023(1):125–34.

Article  Google Scholar 

Ogawa S. Genetics of MDS. Blood. 2019;133(10):1049–59.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kennedy AL, Shimamura A. Genetic predisposition to MDS: clinical features and clonal evolution. Blood. 2019;133(10):1071–85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hirabayashi S, Wlodarski MW, Kozyra E, Niemeyer CM. Heterogeneity of GATA2-related myeloid neoplasms. Int J Hematol. 2017;106(2):175–82.

Article  CAS  PubMed  Google Scholar 

Feurstein S, Godley LA. Germline ETV6 mutations and predisposition to hematological malignancies. Int J Hematol. 2017;106(2):189–95.

Article  CAS  PubMed  Google Scholar 

Noris P, Favier R, Alessi MC, Geddis AE, Kunishima S, Heller PG, et al. ANKRD26-related thrombocytopenia and myeloid malignancies. Blood. 2013;122(11):1987–9.

Article  CAS  PubMed  Google Scholar 

Polprasert C, Schulze I, Sekeres MA, Makishima H, Przychodzen B, Hosono N, et al. Inherited and somatic defects in DDX41 in myeloid neoplasms. Cancer Cell. 2015;27(5):658–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia. 2022;36(7):1703–19.

Narumi S, Amano N, Ishii T, Katsumata N, Muroya K, Adachi M, et al. SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7. Nat Genet. 2016;48(7):792–7.

Article  CAS  PubMed  Google Scholar 

Chen DH, Below JE, Shimamura A, Keel SB, Matsushita M, Wolff J, et al. Ataxia-Pancytopenia syndrome is caused by missense mutations in SAMD9L. Am J Hum Genet. 2016;98(6):1146–58.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tesi B, Davidsson J, Voss M, Rahikkala E, Holmes TD, Chiang SCC, et al. Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms. Blood. 2017;129(16):2266–79.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rudelius M, Weinberg OK, Niemeyer CM, Shimamura A, Calvo KR. The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia. Virchows Arch. 2023;482(1):113–30.

Article  PubMed  Google Scholar 

Jaiswal S, Ebert BL. Clonal hematopoiesis in human aging and disease. Science. 2019;366(6465).

Genovese G, Kahler AK, Handsaker RE, Lindberg J, Rose SA, Bakhoum SF, et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014;371(26):2477–87.

Article  PubMed  PubMed Central  Google Scholar 

Mitchell E, Spencer Chapman M, Williams N, Dawson KJ, Mende N, Calderbank EF, et al. Clonal dynamics of haematopoiesis across the human lifespan. Nature. 2022;606(7913):343–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jaiswal S, Fontanillas P, Flannick J, Manning A, Grauman PV, Mar BG, et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014;371(26):2488–98.

Article  PubMed  PubMed Central  Google Scholar 

Ahmad H, Jahn N, Jaiswal S. Clonal hematopoiesis and its impact on human health. Annu Rev Med. 2023;74:249–60.

Article  CAS  PubMed  Google Scholar 

Cheloor Kovilakam S, Gu M, Dunn WG, Marando L, Barcena C, Nik-Zainal S, et al. Prevalence and significance of DDX41 gene variants in the general population. Blood. 2023;142(14):1185–92.

Article  CAS  PubMed  Google Scholar 

Churpek JE, Pyrtel K, Kanchi KL, Shao J, Koboldt D, Miller CA, et al. Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia. Blood. 2015;126(22):2484–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kennedy AL, Myers KC, Bowman J, Gibson CJ, Camarda ND, Furutani E, et al. Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome. Nat Commun. 2021;12(1):1334.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sebert M, Gachet S, Leblanc T, Rousseau A, Bluteau O, Kim R, et al. Clonal hematopoiesis driven by chromosome 1q/MDM4 trisomy defines a canonical route toward leukemia in Fanconi anemia. Cell Stem Cell. 2023;30(2):153–70 e9.

Sahoo SS, Pastor VB, Goodings C, Voss RK, Kozyra EJ, Szvetnik A, et al. Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes. Nat Med. 2021;27(10):1806–17.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Revy P, Kannengiesser C, Bertuch AA. Genetics of human telomere biology disorders. Nat Rev Genet. 2023;24(2):86–108.

Article  CAS  PubMed  Google Scholar 

Jongmans MC, Verwiel ET, Heijdra Y, Vulliamy T, Kamping EJ, Hehir-Kwa JY, et al. Revertant somatic mosaicism by mitotic recombination in dyskeratosis congenita. Am J Hum Genet. 2012;90(3):426–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Perdigones N, Perin JC, Schiano I, Nicholas P, Biegel JA, Mason PJ, et al. Clonal hematopoiesis in patients with dyskeratosis congenita. Am J Hematol. 2016;91(12):1227–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gutierrez-Rodrigues F, Donaires FS, Pinto A, Vicente A, Dillon LW, Cle DV, et al. Pathogenic TERT promoter variants in telomere diseases. Genet Med. 2019;21(7):1594–602.

Article  CAS